Business Context and Reporting Period
This Form 8-K is a current report filed by Nephros, Inc. on June 22, 2009. The filing addresses a specific corporate governance event rather than periodic financial performance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to the disclosure of personnel changes and contains no financial data.
Material Changes
The material change reported is the departure of a director:
- Eric A. Rose, M.D., a member of the Board of Directors, resigned effective immediately on June 22, 2009.
- The resignation was notified to the Company on the same date.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors related to the resignation. No unusual items or contingencies were disclosed in this document.
Investor Verification Checklist
- Verify the current composition of the Board of Directors following Dr. Rose's resignation.
- Check for any subsequent filings regarding the appointment of a replacement director.
- Review the company's most recent 10-K or 10-Q for financial context, as this 8-K contains no financial metrics.